Novo Nordisk A/S News - July 17, 2026

Novo Nordisk’s Wegovy Secures Indian Approval, First GLP-1 for Liver Disease

The Central Drugs Standard Control Organisation (CDSCO) approved Novo Nordisk’s Wegovy to treat a severe form of fatty liver disease in India. The approval...